BSXNYSESEC EDGAREDGAR

BOSTON SCIENTIFIC CORP

Surgical & Medical Instruments & Apparatus·MARLBOROUGH, MA·FY end 12/31·CIK 885725

Board of Directors

10 members · 9 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
David C. HabigerDirector2y57AuditComp—
Edward J. LudwigLead Independent Director12y74AuditNCG—
Michael F. MahoneyCEO and Director14y61———
Jessica L. MegaDirector3y51CompRiskTech—
Susan E. MoranoDirector3y61AuditNCG—
Cheryl PegusDirector2y62CompRiskTech—
Cathy R. SmithDirector0y62AuditNCG—
Christophe P. WeberDirector0y59CompRiskTech—
David S. WichmannDirector5y63AuditRiskTech—
Ellen M. ZaneDirector10y74CompNCG—

Risk-factor diff

FY 2025 10-K vs. FY 2024
+0 new−0 removed

Net-new paragraphs in the most recent 10-K's Item 1A. Companies rarely add risk language without a real reason — additions here are often a leading signal of management concerns.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.